Andrew Avins to Vaccines, Conjugate
This is a "connection" page, showing publications Andrew Avins has written about Vaccines, Conjugate.
Connection Strength
0.663
-
Immunogenicity and safety of the quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine (MenACWY-TT) in splenectomized or hyposplenic children and adolescents: Results of a phase III, open, non-randomized study. Vaccine. 2018 04 19; 36(17):2356-2363.
Score: 0.304
-
Safety and immunogenicity of a novel quadrivalent meningococcal CRM-conjugate vaccine given concomitantly with routine vaccinations in infants. Pediatr Infect Dis J. 2012 Jan; 31(1):64-71.
Score: 0.197
-
Antibody persistence and booster response following MenACWY-CRM vaccination in children as assessed by two different assay methods. Vaccine. 2019 07 26; 37(32):4460-4467.
Score: 0.083
-
Preterm infants' T cell responses to inactivated poliovirus vaccine. J Infect Dis. 2010 Jan 15; 201(2):214-22.
Score: 0.043
-
Lot-to-lot consistency, safety and immunogenicity of 3 lots of Haemophilus influenzae type b conjugate vaccine: results from a phase III randomized, multicenter study in infants. Vaccine. 2017 06 16; 35(28):3564-3574.
Score: 0.036